https://staging.rare-hub.it/weekly0.5https://staging.rare-hub.it/facultyweekly0.5https://staging.rare-hub.it/gmgweekly0.5https://staging.rare-hub.it/gmg/diagnostica-anticorpale-in-miastenia-gravis-uno-scenario-in-evoluzioneweekly0.5https://staging.rare-hub.it/gmg/eculizumab-nella-gmg-pediatrica-refrattaria-dati-dal-trial-registrativoweekly0.5https://staging.rare-hub.it/gmg/esperienze-real-life-di-trattamento-precoce-in-gmgweekly0.5https://staging.rare-hub.it/gmg/gmg-01-presentazione-liguoriweekly0.5https://staging.rare-hub.it/gmg/la-multidisciplinarieta-nel-trattamento-della-miastenia-gravisweekly0.5https://staging.rare-hub.it/gmg/miastenia-gravis-presentazione-di-un-caso-clinicoweekly0.5https://staging.rare-hub.it/gmg/quadro-clinico-indicazioni-terapeutiche-e-prospettive-future-intervista-allespertoweekly0.5https://staging.rare-hub.it/gmg/quali-nuove-prospettive-terapeutiche-in-miastenia-gravisweekly0.5https://staging.rare-hub.it/gmg/quando-laspettativa-incontra-la-realtaweekly0.5https://staging.rare-hub.it/gmg/razionale-e-benefici-del-trattamento-anticipato-in-gmgweekly0.5https://staging.rare-hub.it/gmg/stabilizzazione-di-malattia-steroid-sparing-ospedalizzazioni-rescue-therapyweekly0.5https://staging.rare-hub.it/gmg/update-sulla-terapia-nella-miastenia-gravisweekly0.5https://staging.rare-hub.it/libraryweekly0.5https://staging.rare-hub.it/nmosdweekly0.5https://staging.rare-hub.it/nmosd/diagnostica-anticorpale-biomarcatori-ed-evoluzione-futura-risonanza-magnetica-alleata-della-diagnosi-e-del-monitoraggioweekly0.5https://staging.rare-hub.it/nmosd/gmg-01-presentazione-lugaresiweekly0.5https://staging.rare-hub.it/nmosd/il-complemento-come-target-terapeuticoweekly0.5https://staging.rare-hub.it/nmosd/il-profilo-di-sicurezza-come-criterio-di-scelta-terapeuticaweekly0.5https://staging.rare-hub.it/nmosd/il-ruolo-dellinibizione-del-complemento-nella-terapia-della-nmosd-dati-di-efficaciaweekly0.5https://staging.rare-hub.it/nmosd/le-terapie-farmacologiche-in-nmosd-efficacia-e-sicurezzaweekly0.5https://staging.rare-hub.it/nmosd/multidisciplinarieta-in-nmosdweekly0.5https://staging.rare-hub.it/nmosd/neuromyelitis-optica-treatment-onset-and-relapseweekly0.5https://staging.rare-hub.it/nmosd/nmosd-e-gravidanzaweekly0.5https://staging.rare-hub.it/nmosd/nmosd-storia-quadro-clinico-e-diagnosi-differenzialeweekly0.5https://staging.rare-hub.it/nmosd/quadro-clinico-indicazioni-terapeutiche-e-prospettive-future-intervista-allespertoweekly0.5https://staging.rare-hub.it/nmosd/safety-legata-alla-real-world-evidence-e-vaccinazione-antimeningococcicaweekly0.5https://staging.rare-hub.it/nmosd/sfide-nella-prevenzione-delle-ricadute-da-nmosdweekly0.5https://staging.rare-hub.it/progettoweekly0.5